For the record - March 24, 2008

Generic drugs: An article in the March 17 Health section about the FDA’s standard of “bioequivalence” to generic drugs said that a comment by neuropsychiatrist Dr. Giuseppe Borgheini about bioequivalence was from a 2004 article in the journal Clinical Therapy. The article was actually published in a 2003 issue of Clinical Therapeutics. The same story incorrectly identified the brand name of the anti-seizure drug valproic acid as Felbatol. The correct brand name is Depakote. Also, the anti-seizure drug phenytoin was identified as Cerebyx. That’s an injectable form, however; the drug is more commonly known as Dilantin.